ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

24 Jun 2018

Repurposing selective PDE5 inhibitors as anti-cancer agents

Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium

5 Jun 2018

First results of DREAM trial of frontline durvalumab for mesothelioma

Prof Anna Nowak - The University of Western Australia, Perth, Australia

5 Jun 2018

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

4 Jun 2018

Chemotherapy plus durvalumab in triple negative breast cancer

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany

4 Jun 2018

Phase II results of olaparib and abiraterone for mCRPC

Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK

4 Jun 2018

Global treatment pattern variations in HCC

Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico

4 Jun 2018

Design and interim safety analysis of GeparX trial

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany

4 Jun 2018

Key developments in non-metastatic and metastatic hormone-sensitive prostate can...

Dr Eleni Efstathiou, Prof Nicholas Mottet, Dr Andrew Armstrong and Prof Maria De...

4 Jun 2018

International cancer control plans

Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana

4 Jun 2018

Economic impact of NGS in non small cell lung cancer

Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA

4 Jun 2018

Subcutaneous daratumumab shows benefit in patients with relapsed or refractory m...

Dr Ajai Chari - Mount Sinai Hospital, New York, USA

4 Jun 2018

Avelumab in combinations for lung cancer and update from ALEX study

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

4 Jun 2018

Updates in melanoma from ASCO 2018

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands

4 Jun 2018

Novel fusion proteins to target PD-L1 in HPV associated cancers

Dr James Gulley - Center for Cancer Research, Washington, USA

4 Jun 2018

Daratumumab in combination with carfilzomib and dexamethasone for relapsed multi...

Dr Ajai Chari - Mount Sinai Hospital, New York, USA

4 Jun 2018

Phase I study results of M7824 for patients with HPV associated cancers

Dr Julius Strauss - Center for Cancer Research, Washington, USA

4 Jun 2018

Phase III results of PROSPECT study for metastatic, castration-resistant prostat...

Dr James Gulley - Center for Cancer Research, Washington, USA

4 Jun 2018

Pancreatic survival improved with trial chemotherapy regimen after surgery

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France

4 Jun 2018

Aspirin combined with acid-reducing medicine offers moderate benefits in patient...

Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...

4 Jun 2018

Pre-operative chemotherapy with radiation may help people with pancreatic cancer...

Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands

4 Jun 2018

Heated abdominal chemotherapy not beneficial in patients with advanced colorecta...

Dr Francois Quenet - Regional Cancer Institute, Montpellier, France

4 Jun 2018

Comment: Pancreatic cancer survival extended by over a year with chemotherapy re...

Dr Andrew Epstein and Prof Richard Schilsky

4 Jun 2018

Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cance...

Dr Andrew Epstein and Prof Richard Schilsky

4 Jun 2018

Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemo...

Dr Andrew Epstein, Prof Richard Schilsky and Dr Geertjan van Tienhoven

4 Jun 2018

Comment: No benefit of heated abdominal chemotherapy in advanced colorectal canc...

Prof Richard Schilsky, Dr Andrew Epstein and Dr Francois Quenet

4 Jun 2018

Pancreatic cancer survival extended by over a year with chemotherapy regimen

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France

4 Jun 2018

Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high...

Prof Janusz Jankowski - Royal College of Surgeons in Ireland, Dublin, Republic o...

4 Jun 2018

Improved 2 year survival for pancreatic cancer with pre-operative chemoradiation

Dr Geertjan van Tienhoven - Academic Medical Center, Amsterdam, Netherlands

4 Jun 2018

No benefit of heated abdominal chemotherapy in advanced colorectal cancer

Dr Francois Quenet - Regional Cancer Institute, Montpellier, France

4 Jun 2018

Dabrafenib halts growth of low-grade paediatric glioma

Dr Mark Kieran - Dana Farber Cancer Institue, Boston, USA

4 Jun 2018

ASCO 2018: Novel treatment strategies in prostate cancer therapeutics

Prof Karim Fizazi and Dr Neal Shore

4 Jun 2018

ASCO 2018: Latest developments in non-metastatic and metastatic castration-resis...

Dr Neal Shore, Dr Simon Chowdhury, Prof Matthew Smith and Prof Boris Hadaschik

3 Jun 2018

Finding appropriate doses for HER2 positive breast cancers

Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA

3 Jun 2018

Updates in targeted therapy for melanoma

Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany

3 Jun 2018

Education, collaboration and communication in global cancer control

Dr Susannah Stanway - Royal Marsden NHS Foundation Trust, London, UK

3 Jun 2018

Health related quality of life findings from COMBI-AD

Prof Dirk Schadendorf - Hospitals Essen-Mitte, Essen, Germany

3 Jun 2018

Developing a survivin vaccine for glioblastoma

Dr Michael Ciesielski - Roswell Park Comprehensive Cancer Center, Buffalo, USA

3 Jun 2018

Early results from a 3rd gen EGFR-TKI in advanced NSCLC

Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea

3 Jun 2018

New pathways in pancreatic cancer

Dr Federico Sanchez - Aurora Sheboygan Memorial Medical Center, Sheboygan, USA

3 Jun 2018

OPTIMISMM trial for refractory multiple myeloma

Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA

3 Jun 2018

Treatment updates in Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA

3 Jun 2018

Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast ...

Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany

3 Jun 2018

New treatment markers for myeloma

Dr Jesus San Miguel - Universidad de Navarra, Pamplona, Spain

3 Jun 2018

Most breast cancer patients could avoid chemo with use of genetic testing

Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA

3 Jun 2018

Pembrolizumab works better than chemotherapy alone as initial treatment for NSCL...

Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA

3 Jun 2018

Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma

Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy

3 Jun 2018

Sunitinib with or without surgery for metastatic renal cell carcinoma

Prof Arnaud Mejean - Paris Descartes University, Paris, France

3 Jun 2018

Comment: Genetic testing of early breast tumours could allow patients to go with...

Dr Harold Burstein & Prof Richard Schilsky

3 Jun 2018

Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer tr...

Dr John Heymach & Prof Richard Schilsky

3 Jun 2018

Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemothe...

Prof Richard Schilsky & Dr Gianni Bisogno

3 Jun 2018

Comment: Kidney surgery may be unneeded in many intermediate-risk patients

Dr Sumanta Pal & Prof Richard Schilsky

3 Jun 2018

Genetic testing of early breast tumours could allow patients to go without chemo

Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA

3 Jun 2018

PD-1 immunotherapy better than chemo alone as first line lung cancer treatment

Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil

3 Jun 2018

Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy

Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy

3 Jun 2018

Kidney surgery may be unneeded in many intermediate-risk patients

Prof Arnaud Mejean - Paris Descartes University, Paris, France

3 Jun 2018

ASCO 2018: Latest in bladder cancer treatments

Prof Thomas Powles & Prof Shahrokh Shariat

3 Jun 2018

Cancer treatment in the last 6 months of life: when inaction can outperform acti...

Dr Bishal Gyawali - Brigham and Women's Hospital, Boston, USA

3 Jun 2018

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer

Prof Kurt Miller and Prof Bertrand Tombal

2 Jun 2018

A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER...

Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA

2 Jun 2018

Zoptarelin no better than doxarubicin for second-line advanced endometrial cance...

Dr David Miller - The University of Texas Southwestern Medical Center

2 Jun 2018

Improving global breast cancer care

Prof Carlos Barrios - Pontifica Universidade Catolica de Rio Grande do Sul, Braz...

2 Jun 2018

What will we expect from novel therapies for oesophageal and gastric malignancie...

Prof Ramon De Mello - University of Algarve, Faro, Portugal

2 Jun 2018

Nelarabine in newly diagnosed paediatric T-cell malignancies

Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA

2 Jun 2018

Immunotherapy trials and hyperprogressive disease

Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

2 Jun 2018

First-in-human phase 1 study of TAK-931 for solid tumours

Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan

2 Jun 2018

Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in...

Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France

2 Jun 2018

The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CL...

Prof William Wierda - MD Anderson Cancer Center, Houston, USA

2 Jun 2018

Development of blood tests for early lung cancer

Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA

2 Jun 2018

Linking Lynch Syndrome and microsatellite instability in tumours

Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA

2 Jun 2018

Matching personalised therapies to patients in the IMPACT trial

Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA

2 Jun 2018

Atezolizumab with chemotherapy improves PFS in squamous NSCLC

Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA

2 Jun 2018

Matching mutations in tumours to precision medicine improves survival

Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA

2 Jun 2018

Development of blood tests for early lung cancer

Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA

2 Jun 2018

Genomic study links several new cancers to Lynch Syndrome

Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA

2 Jun 2018

Taselisib with fulvestrant slows growth of advanced breast cancer

Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA

2 Jun 2018

Atezolizumab with chemotherapy improves PFS in squamous NSCLC

Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA

2 Jun 2018